# Secondhand Tobacco Smoke and Cardiovascular Disease

> **NCT04715568** · PHASE4 · RECRUITING · sponsor: **University of California, San Francisco** · enrollment: 100 (estimated)

## Conditions studied

- Cardiovascular Diseases
- Hypertension

## Interventions

- **DRUG:** Losartan
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04715568
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2021-03-30
- **Primary completion:** 2026-12-31
- **Final completion:** 2026-12-31
- **Target enrollment:** 100 (ESTIMATED)
- **Last updated:** 2025-07-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04715568

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04715568, "Secondhand Tobacco Smoke and Cardiovascular Disease". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04715568. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*